Pre-clinical evidence-based insights into the therapeutic potential of Murraya koenigii (curry patta) with a focus on its future application as an anti-inflammatory drug
DOI:
https://doi.org/10.12923/Keywords:
Murraya koenigii, anti-inflammatory activity, therapeutic potential, pre-clinical evidenceAbstract
In recent years, there has been unprecedented growth in the use of plant-based herbal therapeutics for the management of various disease conditions. Murraya koenigii has a long history of use in India as a food enhancer and for its numerous therapeutic benefits. Various parts of the plant, including leaves, stems, and bark, are traditionally used to treat disorders such as dysentery, renal pain, gastrointestinal disturbances, and morning sickness. Leaf extracts of M. koenigii have been reported to possess cooling, anthelmintic, analgesic, antibacterial, anti-inflammatory, and antipruritic properties. In addition, the leaves are used in the management of leukoderma and as blood-purifying agents. Toasted leaves infused in water are traditionally used as a household remedy to control vomiting, while crushed leaves are applied topically to treat skin eruptions and soothe burns. The present review aims to provide an updated overview of the therapeutic potential of M. koenigii, with a particular emphasis on pre-clinical evidence supporting its anti-inflammatory activity.
References
1. Gurib-Fakim A. Medicinal plants: traditions of yesterday and drugs of tomorrow. Mol Aspects Med. 2006;27(1):1-93.
2. Balakrishnan R, Vijayraja D, Jo SH, Ganesan P, Su-Kim I, Choi DK. Medicinal profile, phytochemistry, and pharmacological activities of Murraya koenigii and its primary bioactive compounds. Antioxidants. 2020;9(2):101.
3. Abeysinghe DT, Alwis DD, Kumara KA, Chandrika UG. Nutritive importance and therapeutic uses of three curry leaf varieties (Murraya koenigii, Micromelum minutum, Clausena indica): an updated review. Evid Based Complement Alternat Med. 2021;2021:1-31.
4. Jain M, Gilhotra R, Singh RP, Mittal J. Curry leaf (Murraya koenigii): a spice with medicinal properties. MOJ Biol Med. 2017;2(3):00050.
5. Chauhan B, Dedania J, Mashru RC. Review on Murraya koenigii: versatile role in management of human health. World J Pharm Pharm Sci. 2017;9(4):476-493.
6. Karthik S, Sahana KG, Babu A, et al. Murraya koenigii: psychopharmacological, traditional and medicinal considerations. Int J Health Care Biol Sci. 2022;26:86-93.
7. Elumalai K, Velmurugan S, Ravi S, Kathiravan V, Ashokkumar S. Bio-fabrication of zinc oxide nanoparticles using curry leaf (Murraya koenigii) extract and its antimicrobial activity. Mater Sci Semicond Process. 2015;34:365-372.
8. Xie JT, Chang WT, Wang CZ, et al. Curry leaf (Murraya koenigii Spreng.) reduces blood cholesterol and glucose levels in ob/ob mice. Am J Chin Med. 2006;34(2):279-284.
9. Satyavarapu EM, Sinha PK, Mandal C. Preclinical development of a mahanine-enriched fraction from Murraya koenigii for cancer management. Biomed Res Int. 2020;2020:1-10.
10. Mitra E, Ghosh AK, Ghosh D, et al. Protective effect of aqueous curry leaf (Murraya koenigii) extract against cadmium-induced oxidative stress in rat heart. Food Chem Toxicol. 2012;50(5):1340-1353.
11. Samanta SK, Kandimalla R, Gogoi B, et al. Phytochemical portfolio and anticancer activity of Murraya koenigii and its primary active component, mahanine. Pharmacol Res. 2018;129:227-236.
12. Romes NB, Abdul Wahab R, Abdul Hamid M. Bioactive phytoconstituent-loaded nanoemulsions for skin improvement: a review. Biotechnol Biotechnol Equip. 2021;35(1):711-730.
13. Mbikay M. Therapeutic potential of Moringa oleifera leaves in chronic hyperglycemia and dyslipidemia. Front Pharmacol. 2012;3:24.
14. Rajanikant SK, Chattree A. Antioxidant and antifungal potential of Murraya koenigii leaf extracts and essential oil. Chem Sci. 2015;4(1):222-226.
15. Jakhar S, Gahlawat DK, Dahiya S, et al. Antibacterial and antioxidant potential of leaf and seed extracts of Murraya koenigii. Br Microbiol Res J. 2015;10(6):1-7.
16. Adebajo AC, Ayoola OF, Iwalewa EO, et al. Anti-trichomonal, biochemical, and toxicological activities of methanolic extract and carbazole alkaloids from Murraya koenigii. Phytomedicine. 2006;13:246-254.
17. Mandal S. Curry plant (Murraya koenigii L.): an indigenous spice plant with versatile medicinal properties. Int J Clin Exp Physiol. 2016;3(2):59-65.
18. Iman V, Mohan S, Abdelwahab SI, et al. Anticancer and anti-inflammatory activities of girinimbine isolated from Murraya koenigii. Drug Des Devel Ther. 2016;10:103-121.
19. Fujiwara N, Kobayashi K. Macrophages in inflammation. Curr Drug Targets Inflamm Allergy. 2005;4(3):281-286.
20. Kurgan S, Kantarci A. Molecular basis of inflammatory changes during gingivitis to periodontitis progression. Periodontol 2000. 2018;76(1):51-67.
21. Turner MD, Nedjai B, Hurst T, Pennington DJ. Cytokines and chemokines at the crossroads of cell signaling and inflammatory disease. Biochim Biophys Acta Mol Cell Res. 2014;1843(11):2563-2582.
22. Chan-Park MB, Shen JY, Cao Y, et al. Biomimetic control of vascular smooth muscle cell phenotype. J Biomed Mater Res A. 2009;88(4):1104-1121.
23. Dudek SM, Garcia JG. Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol. 2001;91(4):1487-1500.
24. Finegold MJ. Pneumonic plague in monkeys: an electron microscopic study. Am J Pathol. 1969;54(2):167-185.
25. deCathelineau AM, Henson PM. Phagocytosis of apoptotic cells. Essays Biochem. 2003;39:105-117.
26. Arunkumar J. Evaluation of anti-inflammatory activity of methanolic extract of Murraya koenigii leaves. Univ J Pre Paraclin Sci. 2021;7(1).
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Pralaya Kumar Sahoo, Bhabani Sankar Satapathy, Biswabhusan Biswal, Snigdha Pattnaik, Laxmidhar Maharana (Autor)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
